Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Watts

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic reviewChristopher P Millward, Abdurrahman I Islim, Terri S Armstrong, et al.
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic reviewChristopher P Millward, Sumirat M Keshwara, Terri S Armstrong, et al.
Neuro-Oncology|June 12, 2016
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activationEskil Eskilsson, Gro V Rosland, Krishna M Talasila, et al.
Trials|September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials unitsSharon B Love, Fay Cafferty, Claire Snowdon, et al.
BMJ Open|May 9, 2022
Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetingsChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Neuro-Oncology Advances|May 31, 2021
CovidNeuroOnc: A UK multicenter, prospective cohort study of the impact of the COVID-19 pandemic on the neuro-oncology serviceDaniel M Fountain, Rory J Piper, Michael T C Poon, et al.
Neuron|September 29, 2022
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cellsHarry Bulstrode, Gemma C Girdler, Tannia Gracia, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
Neuro-Oncology|March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncologyChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic reviewChristopher P Millward, Abdurrahman I Islim, Terri S Armstrong, et al.
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic reviewChristopher P Millward, Sumirat M Keshwara, Terri S Armstrong, et al.
Neuro-Oncology|June 12, 2016
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activationEskil Eskilsson, Gro V Rosland, Krishna M Talasila, et al.
Trials|September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials unitsSharon B Love, Fay Cafferty, Claire Snowdon, et al.
BMJ Open|May 9, 2022
Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetingsChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Neuro-Oncology Advances|May 31, 2021
CovidNeuroOnc: A UK multicenter, prospective cohort study of the impact of the COVID-19 pandemic on the neuro-oncology serviceDaniel M Fountain, Rory J Piper, Michael T C Poon, et al.
Neuron|September 29, 2022
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cellsHarry Bulstrode, Gemma C Girdler, Tannia Gracia, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
Neuro-Oncology|March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncologyChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
Pageof 19